X-LINKED CHRONIC GRANULOMATOUS DISEASE
Clinical trials for X-LINKED CHRONIC GRANULOMATOUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new X-LINKED CHRONIC GRANULOMATOUS DISEASE trials appear
Sign up with your email to follow new studies for X-LINKED CHRONIC GRANULOMATOUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New gene therapy aims to fix immune system in rare disease
Disease control Recruiting nowThis study tests a new gene therapy called EN-374 for people with X-linked chronic granulomatous disease (X-CGD), a rare immune disorder that leads to severe infections. The treatment uses a modified virus to deliver a working gene to help the body produce infection-fighting cell…
Matched conditions: X-LINKED CHRONIC GRANULOMATOUS DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Ensoma • Aim: Disease control
Last updated May 26, 2026 05:02 UTC
-
Gene-Editing breakthrough aims to fix immune cells in rare disease
Disease control Recruiting nowThis early-stage trial tests a new gene-editing technique (base editing) to repair a specific genetic mutation in people with X-linked chronic granulomatous disease (X-CGD), a rare immune disorder. Up to 10 adults will have their own blood stem cells collected, edited in a lab, a…
Matched conditions: X-LINKED CHRONIC GRANULOMATOUS DISEASE
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 22, 2026 14:03 UTC